Close this search box.

Addressing Access Barriers for IgG4-RD Patients

A rare condition known as IgG4-related disease, or IgG4-RD, can burden patients with a complex web of symptoms, trouble obtaining a diagnosis and a seemingly endless series of treatment barriers. Many patients experience significant emotional and financial impacts too. Read White Paper

The High Costs of Alternative Funding

In the United States, health insurance is meant to reduce patients’ financial risks if they require expensive medical services. It often fails to do so. The problem is particularly acute for patients who need expensive prescription medications.

The Indirect Impact of RSV

RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2.

Health Disparities & Medication Access

At some point in their lives, most patients encounter insurance delays or denials for a prescription medication. But do certain groups of patients encounter these barriers more often than others? And at what cost?